Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Denver, Colorado 80262


Purpose:

To determine the maximum tolerated dose and safety profile of S-3304 in patients with biopsy accessible cancer who have failed previous therapy or to whom no standard therapies are available. To determine the pharmacokinetic profile of S-3304 in this patient population


Criteria:

Inclusion criteria: - Biopsy proven diagnosis of solid tumor(s) with biopsy accessible lesion(s) - Must be able to tolerate oral medication Exclusion criteria - Patients with other serious illnesses - Patients who are receiving treatments


NCT ID:

NCT00033215


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Denver, Colorado 80262
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.